Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Frohlich, Anita
NCT04279522: The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)	Completed	N/A	126	US, RoW	Relivion®DP- Active, Relivion®DP- Sham	Neurolief Ltd.	MDD	06/24	06/24
Holland, Bridgette
NCT04279522: The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)	Completed	N/A	126	US, RoW	Relivion®DP- Active, Relivion®DP- Sham	Neurolief Ltd.	MDD	06/24	06/24
NCT04557891: Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)	Recruiting	N/A	48	US	Active LIFUP Treatment, BX Pulsar 1002, Sham LIFUP Treatment	University of California, Los Angeles, Massachusetts General Hospital, Medical University of South Carolina	Generalized Anxiety Disorder	12/25	12/25
Pruden, Mary
NCT06303739: Psilocybin-Assisted Therapy in Treatment-Resistant Depression	Recruiting	3	20	US	psilocybin	University of North Carolina, Chapel Hill, Foundation of Hope, North Carolina	Refractory Depression, Treatment Resistant Depression	09/25	09/26
NCT04279522: The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)	Completed	N/A	126	US, RoW	Relivion®DP- Active, Relivion®DP- Sham	Neurolief Ltd.	MDD	06/24	06/24